{"schema_version":"1.0","type":"article","title":"我們離真正的抗老藥，究竟還有多遠？","url":"https://drugnews.com.tw/articles/2026-04-05-dcard-261238352.html","markdown_url":"https://drugnews.com.tw/articles/2026-04-05-dcard-261238352.md","lang":"zh-Hant","date":"2026-04-05","publish_at":"2026-04-05T10:30:00+08:00","updated_at":"2026-04-05","category":"商業分析系列","topic":"商業分析系列","tags":["商業分析系列","免費文章","臨床數據","生技投資"],"summary":"「抗老化」這三個字，很容易讓人聯想到不老神話、富人專屬科技，甚至公平性與可近性的爭議。","key_points":[],"facts":[],"sections":["問題的第一道門檻：老化還不是一個成熟的藥物適應症","WHO 的語言正在鬆動，但還沒真的把老化醫療化","從生物學來看，老化根本不是單一路徑失控","現在最有機會往前走的，很多其實是「舊藥新用」","真正被高分看好的，未必是市場最愛講故事的那一批","NAD+、NMN、NR 很紅，但臨床證據其實還不夠硬","NAD+ 靜脈輸注現在更像 wellness 服務，不是成熟藥物治療","真正值得追蹤的 NAD+ 路線，反而是先走疾病適應症","真正把整個領域卡住的，還是臨床試驗設計","我們已經有很多「時鐘」，但還沒有一個能單獨說服 FDA","所以，我們到底離真正的抗老藥還有多遠？"],"references":[{"title":"[0]: 各公司官網＆公開資料","source":"","date":"","url":""},{"title":"[1]:","source":"","date":"","url":""},{"title":"Healthy ageing and functional ability","source":"","date":"","url":""},{"title":"https://www.who.int/news-room/questions-and-answers/item/healthy-ageing-and-functional-ability","source":"","date":"","url":"https://www.who.int/news-room/questions-and-answers/item/healthy-ageing-and-functional-ability"},{"title":"www.who.int","source":"","date":"","url":""},{"title":"\"Healthy ageing and functional ability\"","source":"","date":"","url":""},{"title":"[2]:","source":"","date":"","url":""},{"title":"Lock","source":"","date":"","url":""},{"title":"Aging lacks disease status, but new classifications are opening regulatory dialogue. Regulatory frameworks are limited, yet trial innovations are moving the field forward. Validated biomarkers are needed, and global efforts toward standardization ...","source":"","date":"","url":""},{"title":"pmc.ncbi.nlm.nih.gov","source":"","date":"","url":""},{"title":"\"","source":"","date":"","url":""},{"title":"Advancing Geroscience Research – A Scoping Review of Regulatory Environments for Gerotherapeutics - PMC\"","source":"","date":"","url":""},{"title":"[3]:","source":"","date":"","url":""},{"title":"\"Old age\"","source":"","date":"","url":""},{"title":"https://www.who.int/standards/classifications/frequently-asked-questions/old-age","source":"","date":"","url":"https://www.who.int/standards/classifications/frequently-asked-questions/old-age"},{"title":"www.who.int","source":"","date":"","url":""},{"title":"\"","source":"","date":"","url":""},{"title":"\\\"Old age\\\"\"","source":"","date":"","url":""},{"title":"[4]:","source":"","date":"","url":""},{"title":"Hallmarks of aging: An expanding universe","source":"","date":"","url":""},{"title":"Aging is a complex and multifactorial process. This reprise of the 2013 “The hallmarks of aging” reviews conceptual progress, additional hallmarks of aging, their interconnection, and preclinical anti-aging manipulations.","source":"","date":"","url":""},{"title":"www.cell.com","source":"","date":"","url":""},{"title":"[5]:","source":"","date":"","url":""},{"title":"Human trials exploring anti-aging medicines","source":"","date":"","url":""},{"title":"Here, we summarize the current knowledge on eight promising drugs and natural compounds that have been tested in the clinic: metformin, NAD<sup>+</sup> precursors, glucagon-like peptide-1 receptor agonists, TORC1 inhibitors, spermidine, senolytics, probio","source":"","date":"","url":""},{"title":"pubmed.ncbi.nlm.nih.gov","source":"","date":"","url":""},{"title":"\"Human trials exploring anti-aging medicines - PubMed\"","source":"","date":"","url":""}],"images":[{"alt":"Dcard 原圖：我們離真正的抗老藥，究竟還有多遠？（圖 1）","url":"https://drugnews.com.tw/assets/articles/dcard-261238352/dcard-01.webp"},{"alt":"Dcard 原圖：我們離真正的抗老藥，究竟還有多遠？（圖 2）","url":"https://drugnews.com.tw/assets/articles/dcard-261238352/dcard-02.webp"},{"alt":"Dcard 原圖：我們離真正的抗老藥，究竟還有多遠？（圖 3）","url":"https://drugnews.com.tw/assets/articles/dcard-261238352/dcard-03.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/dcard-261238352/dcard-01.webp","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-04-05）。我們離真正的抗老藥，究竟還有多遠？。https://drugnews.com.tw/articles/2026-04-05-dcard-261238352.html","disclaimer":"本文僅供產業研究與知識分享，不構成投資、醫療、募資或個股建議。","translations":{"en":"2026-04-05-dcard-261238352-en.html"},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}